Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 PUREFLEX Found to Reduce Loss of Knee Cartilage - Nutraceuticals World

What are you searching for?

Sign in
Research

PUREFLEX Found to Reduce Loss of Knee Cartilage

By: Lisa Olivo

, Rodman Media

A new study has indicated that adding TSI Group’s proprietary processed PUREFLEX brand low molecular weight chondroitin sulfate to a glucosamine sulfate regimen provided a statistically significant reduction in loss of knee cartilage. The randomized, double blind and placebo-controlled Long-Term Evaluation of Glucosamine Sulfate (LEGS) study evaluated 605 subjects at the University of Sydney, Australia and was published last month by the BMJ Group.
 
The cartilage loss was measured as knee joint space narrowing (JSN). After two years of once-daily treatment with 1500 mg of glucosamine and 800 mg of TSI’s chondroitin, the reduction in JSN was approximately half of that demonstrated in the placebo group.
 
“These findings have exciting implications for knee joint sufferers,” said TSI Group’s CEO Joe Zhou. “We’re enthusiastic about the potential of PUREFLEX chondroitin as a tool in the fight against pervasive and difficult knee joint conditions.”
 
For more information: www.tsiinc.com

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics